Last updated on August 2019

A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque Psoriasis

Brief description of study

The objectives of this study are to evaluate the usability of the combination product of risankizumab in an autoinjector (AI), as well as to evaluate the efficacy, safety, and tolerability of risankizumab administered by AI for the treatment of participants with moderate to severe plaque psoriasis.

Clinical Study Identifier: NCT03875508

Find a site near you

Start Over

Tien Q Nguyen MD, Inc /ID# 210775

Fountain Valley, CA United States
  Connect »

DermAssociates /ID# 210838

Rockville, MD United States
  Connect »

Temple /ID# 210772

Philadelphia, PA United States
  Connect »

Mercyhealth East /ID# 212610

Janesville, WI United States
  Connect »